Trial Profile
A randomised, double-blind, placebo-controlled study to evaluate the safety and efficacy of two different doses of phenserine-tartrate in patients with probable mild to moderate Alzheimer's disease.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 26 May 2011
Price :
$35
*
At a glance
- Drugs Phenserine (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Sponsors Horizon Therapeutics plc
- 26 May 2011 New trial record